NCT00244816 2025-10-23Taxoprexin® Treatment for Advanced Eye MelanomaAmerican Regent, Inc.Phase 2 Completed22 enrolled
NCT00249262 2025-09-26Taxoprexin Treatment for Advanced Skin MelanomaAmerican Regent, Inc.Phase 2 Completed30 enrolled